MetLife, Inc. $MET Shares Bought by Groupama Asset Managment

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Groupama Asset Managment boosted its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 11.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 632,396 shares of the financial services provider's stock after buying an additional 62,650 shares during the quarter. Groupama Asset Managment owned approximately 0.09% of MetLife worth $50,105,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of MET. Price T Rowe Associates Inc. MD boosted its position in MetLife by 33.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,663,239 shares of the financial services provider's stock valued at $2,019,427,000 after purchasing an additional 6,213,923 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of MetLife by 0.4% in the 1st quarter. Bank of New York Mellon Corp now owns 8,862,835 shares of the financial services provider's stock valued at $711,597,000 after buying an additional 36,177 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of MetLife by 0.8% in the 1st quarter. Northern Trust Corp now owns 7,109,423 shares of the financial services provider's stock valued at $570,816,000 after buying an additional 57,221 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of MetLife by 3.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 6,671,435 shares of the financial services provider's stock worth $535,568,000 after buying an additional 236,698 shares during the last quarter. Finally, Invesco Ltd. raised its stake in shares of MetLife by 1.4% during the 1st quarter. Invesco Ltd. now owns 6,462,541 shares of the financial services provider's stock worth $518,877,000 after acquiring an additional 87,344 shares in the last quarter. Institutional investors own 94.99% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Wall Street Zen lowered MetLife from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a research report on Monday, August 11th. Barclays lifted their target price on shares of MetLife from $88.00 to $94.00 and gave the stock an "overweight" rating in a research note on Monday, July 7th. JPMorgan Chase & Co. raised their price target on shares of MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Finally, UBS Group lowered their price objective on shares of MetLife from $94.00 to $91.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Ten analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and an average price target of $95.60.

MetLife Stock Performance

NYSE MET traded up $0.1130 on Thursday, reaching $79.1430. 1,960,078 shares of the company's stock traded hands, compared to its average volume of 3,610,517. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market cap of $52.63 billion, a price-to-earnings ratio of 13.41, a P/E/G ratio of 0.71 and a beta of 0.85. The stock has a 50 day moving average price of $77.82 and a 200-day moving average price of $78.56.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same period in the prior year, the business posted $2.28 earnings per share. MetLife's revenue for the quarter was down 2.7% on a year-over-year basis. Equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be given a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 2.9%. The ex-dividend date is Tuesday, August 5th. MetLife's dividend payout ratio is currently 38.47%.

MetLife declared that its board has authorized a share repurchase plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 5.9% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its shares are undervalued.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.